More reads
- Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world? (Washington Post)
- The Washington Post points the finger at Pfizer for staying mum about an Alzheimer’s study. But there’s more to the story than that. (Endpoints)
- Two more big states take aim at PBM pricing practices, which one lawmaker calls ‘the wild west.’ (STAT Plus)
No hay comentarios:
Publicar un comentario